文献速递血管炎

巨细胞动脉炎患者的骨髓增殖性肿瘤与克隆性造血:病例对照与探索性研究

Myeloproliferative neoplasms and clonal haematopoiesis in patients with giant cell arteritis: a case-control and exploratory study.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

该病例对照研究比较21例合并骨髓增殖性肿瘤(MPN)的巨细胞动脉炎(GCA)患者与42例年龄性别匹配的无MPN的GCA患者,发现MPN组头颅症状更少、基线血小板更高、总生存更短;另对18例无MPN的GCA患者行NGS筛查,15例可评估者中33%检出克隆性造血(CH)。

要点

  • 合并MPN的GCA患者头颅症状较少(71.4% vs 97.6%,P=0.004)。
  • 合并MPN的GCA患者基线血小板更高(485×10^9/l vs 346×10^9/l,P=0.02)。
  • 合并MPN的GCA患者总生存更短(HR 8.2,95%CI 1.2–56.6,P=0.03)。

核心结论

  • 合并MPN的GCA患者较无MPN的GCA患者基线血小板更高且总生存更短。
  • GCA与MPN的关联可能并非偶然,二者或存在病理生理联系。
  • 无MPN的GCA患者中克隆性造血检出率为33%,可能高于同年龄预期患病率,需更大队列确认。

研究设计与样本

  • 回顾性病例对照研究比较21例合并MPN的GCA患者与42例年龄性别匹配的无MPN的GCA患者。
  • 另对18例无MPN的GCA患者通过下一代测序(NGS)筛查克隆性造血,其中15例可评估。

主要发现

  • 最常关联的MPN为原发性血小板增多症(ET,n=11)。
  • 合并MPN的GCA患者头颅症状发生率为71.4%,无MPN对照组为97.6%(P=0.004)。
  • 合并MPN的GCA患者基线血小板计数为485×10^9/l(四分位距346–586),对照组为346×10^9/l(296–418),P=0.02。
  • 两组其他临床特征无差异。
  • 合并MPN的GCA患者总生存显著短于对照组(HR 8.2,95%CI 1.2–56.6,P=0.03)。

临床怎么用

  • 对GCA患者应关注是否合并MPN,尤其血小板显著升高者。
  • 合并MPN的GCA患者头颅症状可能不典型,需警惕漏诊。
  • 合并MPN的GCA患者总生存更短,或需更密切随访。

局限性

  • 样本量小(MPN组21例,对照组42例,CH筛查仅15例可评估)。
  • 为回顾性设计。
  • CH检出率高于同年龄预期患病率的推测需更大队列确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: GCA is a large vessel vasculitis for which triggering factors remain unknown. Clonal haematopoiesis (CH) was associated with atherosclerosis through the induction of inflammation in myeloid cells, and data suggest that CH expansion and inflammation may support each other to induce a pro-inflammatory loop. Our objective was to describe the impact of JAK2p.V617F-mutated myeloproliferative neoplasms (MPNs) on GCA and to screen MPN-free patients for CH mutations. METHODS: We performed a retrospective case-control study comparing the characteristics of 21 GCA patients with MPN and 42 age- and gender-matched GCA patients without MPN. Also, 18 GCA patients were screened for CH through next-generation sequencing (NGS). RESULTS: The most frequent associated MPN was essential thrombocythaemia (ET; n = 11). Compared with controls, GCA patients with MPN had less-frequent cephalic symptoms (71.4 vs 97.6%; P = 0.004) and higher platelet counts at baseline [485 × 109/l (interquartile range 346-586) vs 346 (296-418); P = 0.02]. There was no difference between groups for other clinical features. Overall survival was significantly shorter in patients with MPN compared with controls [hazard ratio 8.2 (95% CI 1.2, 56.6); P = 0.03]. Finally, screening for CH using NGS in 15 GCA patients without MPN revealed CH in 33%. CONCLUSION: GCA patients with MPN display higher platelet counts and shorter overall survival than controls. This association is not fortuitous, given the possible pathophysiological relationship between the two diseases. CH was found in one-third of GCA patients, which may be higher than the expected prevalence for a similar age, and should be confirmed in a larger cohort.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Papo M, Friedrich C, Delaval L, et al. Myeloproliferative neoplasms and clonal haematopoiesis in patients with giant cell arteritis: a case-control and exploratory study. Rheumatology (Oxford). 2022. PMID: 33836046. doi:10.1093/rheumatology/keab337

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。